Drugs / DC/LNCaP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00289341 | Mar 2002 → Nov 2008 | prostate cancer | Rockefeller University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DC/LNCaP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00289341 ↗ |
| Route | Subcutaneous | “Subcutaneous injection of DC/LNCaP, DC/LNCaP-M1, DC/KLH” NCT00289341 ↗ |